kb 5492 has been researched along with Gastric Ulcer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, H; Harada, Y; Sukamoto, T; Tanaka, K | 1 |
| Morimoto, Y; Oshima, S; Shimohara, K; Sukamoto, T | 1 |
| Niida, H; Okabe, S; Shimohara, K | 1 |
3 other study(ies) available for kb 5492 and Gastric Ulcer
| Article | Year |
|---|---|
Sigma receptor-mediated effects of a new antiulcer agent, KB-5492, on experimental gastric mucosal lesions and gastric alkaline secretion in rats.
Topics: Animals; Anti-Ulcer Agents; Autoradiography; Carbazoles; Ethanol; Gastric Mucosa; Guanidines; Haloperidol; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Stomach Ulcer; Stress, Physiological | 1994 |
Effects of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and gastric mucosal defensive factors, as compared to those of teprenone and cimetidine.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cimetidine; Diterpenes; Gastric Acid; Gastric Mucosa; Hexosamines; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
Effects of KB-5492, 1-(3,4,5-trimethoxybenzyl)-4-((4-methoxyphenyl)oxycarbonylmethyl) p iperazine monofumarate monohydrate, on gastric lesions and gastric secretion in rats.
Topics: Animals; Anti-Ulcer Agents; Chalcone; Chalcones; Gastric Mucosa; Immersion; Male; Piperazines; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1990 |